$ Value
$1.7M
Shares
18,542
Price
$90
Filed
Dec 3
Insider
Name
Kline Kyle
Title
Senior Vice President, CFO
CIK
0002080625
Roles
Transaction Details
Transaction Date
2025-12-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated August 25, 2025 executed by the reporting person. | These options were granted on March 24, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. | These options were granted on February 27, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. | These options were granted on January 25, 2021 and are fully vested. | These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
Filing Info
Kline Kyle's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-21 | GMED | A | $0 |
| 2026-01-08 | GMED | M | $186K |
| 2026-01-08 | GMED | ▼ | $363K |
| 2026-01-08 | GMED | M | $0 |
| 2025-12-01 | GMED | M | $194K |
| 2025-12-01 | GMED | M | $282K |
| 2025-12-01 | GMED | M | $322K |
| 2025-12-01 | GMED | ▼ | $1.7M |
| 2025-12-01 | GMED | M | $0 |
| 2025-12-01 | GMED | M | $0 |
Other Insiders at GMED (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Huller Kelly
EVP, GC, Corporate Secretary
|
— | $2.8M | 2026-02-25 |